Cargando…
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
There is growing evidence for the role of cancer stem-cells in drug resistance, but with few in situ studies on human tumor samples to decipher the mechanisms by which they resist anticancer agents. Triple negative breast cancer (TNBC) is the most severe sub-type of breast cancer, occurring in young...
Autores principales: | Bousquet, Guilhem, Bouchtaoui, Morad El, Sophie, Tan, Leboeuf, Christophe, de Bazelaire, Cédric, Ratajczak, Philippe, Giacchetti, Sylvie, de Roquancourt, Anne, Bertheau, Philippe, Verneuil, Laurence, Feugeas, Jean-Paul, Espié, Marc, Janin, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471047/ https://www.ncbi.nlm.nih.gov/pubmed/28445132 http://dx.doi.org/10.18632/oncotarget.16925 |
Ejemplares similares
-
High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019) -
Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes
por: Furet, Elise, et al.
Publicado: (2017) -
Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018) -
Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2014) -
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2015)